Transvaginal biological graft showed no clear difference in surgery for recurrent prolapse (1 to 2 years) compared with native tissue repair (moderate certainty).
Transvaginal biological graft showed no clear difference in recurrent prolapse on examination compared with native tissue repair (low certainty).
Transvaginal biological graft showed no clear difference in visceral injury compared with native tissue repair (low certainty).
It is very uncertain whether transvaginal biological graft changes bladder function compared with native tissue repair (very low certainty).
Transvaginal biological graft showed no clear difference in painful intercourse ‐ de novo dyspareunia compared with native tissue repair (moderate certainty).
It is very uncertain whether transvaginal biological graft changes quality of life compared with native tissue repair (very low certainty).
Transvaginal biological graft showed no clear difference in awareness of prolapse (1 to 3 years) compared with native tissue repair (moderate certainty).